Prediction of reversibility of intestinal mucosal damage after ischemia-reperfusion injury by plasma intestinal fatty acid-binding protein levels in pigs

Perfusion (United Kingdom)

Volumn 30, Issue 8, 2015, Pages 617-625

  Kano, H ^a   Okada, K ^a   Morimoto, K ^a   Bao, W ^a   Fukase, K ^a   Ito, A ^b   Okita, Y ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

cardiovascular surgery; E cadherin; intestinal fatty acid binding protein; intestinal ischemia; reperfusion injury

Indexed keywords

FATTY ACID BINDING PROTEIN 2; KI 67 ANTIGEN; UVOMORULIN; BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA OCCLUSION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DELAYED DIAGNOSIS; DESCENDING AORTA; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE MODEL; EPITHELIZATION; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM; INTESTINE INJURY; INTESTINE ISCHEMIA; JEJUNUM; MALE; NONHUMAN; PIG; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REPERFUSION INJURY; UPREGULATION; ANIMAL; BLOOD; COMPLICATION; ENZYME IMMUNOASSAY; INJURIES; INTESTINAL DISEASES; INTESTINE MUCOSA; PATHOLOGY; PREDICTIVE VALUE; VASCULARIZATION;

ANIMALS; BIOMARKERS; FATTY ACID-BINDING PROTEINS; FEMALE; IMMUNOENZYME TECHNIQUES; INTESTINAL DISEASES; INTESTINAL MUCOSA; MALE; PREDICTIVE VALUE OF TESTS; REPERFUSION INJURY; SWINE;

EID: 84945894409     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659114566063     Document Type: Article

References (23)

1. D'Ancona G, Baillot R, Poirier B, et al. Determinants of gastrointestinal complications in cardiac surgery. Tex Heart Inst J 2003; 30: 280-285.
2. Evennett NJ, Petrov MS, Mittal A, Windsor JA,. Systematic review and pooled estimates for the diagnostic accuracy of serological markers for intestinal ischemia. World J Surg 2009; 33: 1374-1383.
3. Pelsers MM, Namiot Z, Kisielewski W, et al. Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem 2003; 36: 529-535.
4. Derikx JP, van Waardenburg DA, Thuijls G, et al. New insight in loss of gut barrier during major non-abdominal surgery. PLoS One 2008; 3: e3954.
5. Derikx JP, Vreugdenhil AC, Van den Neucker AM, et al. A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP. J Clin Gastroenterol 2009; 43: 727-733.
6. Kanda T, Tsukahara A, Ueki K, et al. Diagnosis of ischemic small bowel disease by measurement of serum intestinal fatty acid-binding protein in patients with acute abdomen: a multicenter, observer-blinded validation study. J Gastroenterol 2011; 46: 492-500.
7. Kanda T, Fujii H, Tani T, et al. Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology 1996; 110: 339-343.
8. Thuijls G, van WK, Grootjans J, et al. Early diagnosis of intestinal ischemia using urinary and plasma fatty acid binding proteins. Ann Surg 2011; 253: 303-308.
9. Adriaanse MP, Tack GJ, Passos VL, et al. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies. Aliment Pharmacol Ther 2013; 37: 482-490.
10. Sonnino R, Ereso G, Arcuni J, Franson R,. Human intestinal fatty acid binding protein in peritoneal fluid is a marker of intestinal ischemia. Transplant Proc 2000; 32: 1280.
11. Takeichi M,. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 1451-1455.
12. Block T, Nilsson TK, Bjorck M, Acosta S,. Diagnostic accuracy of plasma biomarkers for intestinal ischaemia. Scand J Clin Lab Invest 2008; 68: 242-248.
13. Derikx JP, Matthijsen RA, de Bruine AP, et al. Rapid reversal of human intestinal ischemia-reperfusion induced damage by shedding of injured enterocytes and reepithelialisation. PLoS One 2008; 3: e3428.
14. Acosta S, Nilsson T,. Current status on plasma biomarkers for acute mesenteric ischemia. J Thromb Thrombolysis 2012; 33: 355-361.
15. Swank GM, Deitch EA,. Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg 1996; 20: 411-417.
16. Vermeulen Windsant IC, Hellenthal FA, et al. Circulating intestinal fatty acid-binding protein as an early marker of intestinal necrosis after aortic surgery: a prospective observational cohort study. Ann Surg 2012; 255: 796-803.
17. Chang M, Kistler EB, Schmid-Schonbein GW,. Disruption of the mucosal barrier during gut ischemia allows entry of digestive enzymes into the intestinal wall. Shock 2012; 37: 297-305.
18. Doig CJ, Sutherland LR, Sandham JD, Fick GH, Verhoef M, Meddings JB,. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med 1998; 158: 444-451.
19. Goto T, Ishizaka A, Katayama M, et al. Involvement of E-cadherin cleavage in reperfusion injury. Eur J Cardiothorac Surg 2010; 37: 426-431.
20. Acosta S, Nilsson TK, Malina J, Malina M,. L-lactate after embolization of the superior mesenteric artery. J Surg Res 2007; 143: 320-328.
21. Fahrner R, Beyoglu D, Beldi G, Idle JR,. Metabolomic markers for intestinal ischemia in a mouse model. J Surg Res 2012; 178: 879-887.
22. Eltarawy IG, Etman YM, Zenati M, Simmons RL, Rosengart MR,. Acute mesenteric ischemia: the importance of early surgical consultation. Am Surg 2009; 75: 212-219.
23. Kozuch PL, Brandt LJ,. Review article: diagnosis and management of mesenteric ischaemia with an emphasis on pharmacotherapy. Aliment Pharmacol Ther 2005; 21: 201-215.